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Abstract 24 
Objectives:  It has been demonstrated that the efficiency of lethal photosensitisation  25 
can be improved by covalently binding photosensitising agents to bacteriophage.  In 26 
this study we have investigated whether a bacteriophage requires the capacity to 27 
infect the bacterium to enhance lethal photosensitisation when linked to a 28 
photosensitizer.  29 
 30 
Methods:  Tin (IV) chlorin e6 (SnCe6) was conjugated to bacteriophage Φ11, a 31 
transducing phage which can infect Staphylococcus aureus NCTC 8235-4, but not 32 
EMRSA 16.  The conjugate and  appropriate controls, were incubated with these 33 
bacteria and either exposed to laser light at 632.8 nm or kept in the dark. 34 
 35 
Results:  The SnCe6 / Φ11 conjugate achieved a statistically significant reduction in 36 
the number of viable bacteria of both 8325-4 and EMRSA 16 strains by 2.31 log10 37 
and 2.63 log10 respectively.  The conjugate could not however instigate lethal 38 
photosensitisation in E. coli.  None of the other combinations of controls; such as an 39 
equivalent concentration of SnCe6 only, an equivalent titre of bacteriophage only or 40 
experiments conducted without laser light; yielded significant reductions in the 41 
number of viable bacteria recovered. 42 
 43 
Conclusions:  The inability of a bacteriophage to infect S. aureus does not prevent it 44 
from specifically delivering a photosensitiser to a bacterium enabling its lethal 45 
photosensitisation.46 
Introduction 47 
Light-activated antimicrobial agents (photosensitisers) are an appealing alternative to 48 
conventional antibiotics for the treatment of localised bacterial infections.  Lethal 49 
photosensitisation (LP) has been demonstrated to be effective at killing a range of 50 
bacteria including opportunistic pathogens, commensal cutaneous species,1 51 
periodontal pathogens2 and epidemic methicillin-resistant Staphylococcus aureus 52 
(EMRSA).3  LP has two main advantages over conventional antimicrobial 53 
chemotherapy.  Firstly, the bactericidal effect is limited to the area that is treated with 54 
both the photosensitiser and light, preventing disturbance of the wider commensal 55 
microbial community.4  Secondly, the non-specific mode of action of liberated singlet 56 
oxygen (1O2) against bacteria is unlikely to induce the development of protective 57 
mechanisms and the subsequent proliferation of these genes through the wider 58 
microbial community. 59 
 60 
The inherent reactivity of 1O2 limits its ability to diffuse through an aqueous 61 
environment.  The lifetime of 1O2 in pure water is ~4 µs, which results in a theoretical 62 
diffusion distance of 125 nm, if one assumes that the moiety does not interact with a 63 
biological molecule.5  This short range action (on the scale of biological systems) 64 
may possibly limit the effectiveness of LP.  We have previously developed 65 
methodologies to facilitate the close association of photosensitiser and bacteria 66 
using targeting systems based upon the covalent conjugation of the photosensitiser 67 
tin (IV) chlorin e6 (SnCe6) onto immunoglobulin G (IgG).3, 6  More recently, we have 68 
found that covalently linking SnCe6 to S. aureus bacteriophage 75, commonly used 69 
for typing, targets lethal photosensitisation to a range of strains of S. aureus 70 
including MRSA.7  In the study reported herein, we examined whether another 71 
unrelated S. aureus bacteriophage, phage Φ11 a generalised transducing phage, 72 
could replace phage 75 in targeting lethal photosensitisation to S. aureus strains. 73 
 74 
Materials and Methods 75 
Bacteria and Bacteriophage 76 
The two strains of S. aureus used in these experiments were EMRSA-16 (NCTC 77 
13143), one of the dominant nosocomial MRSA isolates in UK hospitals and 8325-4, 78 
a prophage-free derivative of NCTC8325 which is methicillin-sensitive.  These 79 
strains were grown on Columbia agar (Oxoid Ltd., Basingstoke, United Kingdom) 80 
supplemented with 5% (vol/vol) defibrinated horse blood (CBA).  E. coli 10418 was 81 
also incorporated as a Gram-negative control.  In preparation for the lethal 82 
photosensitisation experiments, a colony was inoculated into 20 mL of nutrient broth 83 
no. 2 (NB2) containing 10 mM CaCl2 and grown aerobically for 16 hours at 37ºC in a 84 
shaking incubator.  The cultures were then washed by centrifugation and re-85 
suspension in PBS containing 10 mM CaCl2 and adjusted to a final optical density of 86 
0.05 at 600 nm (OD600), these cell suspensions contained approximately 1 x 10
7 87 
cfu/mL. 88 
 89 
Bacteriophage Φ11 is a generalised transducing phage present in S. aureus NCTC 90 
8235 as a prophage.8  This bacteriophage can infect the NCTC8325 derivative 8325-91 
4, but not EMRSA16.  Phage Φ11 was propagated in S. aureus 8325-4 using the 92 
phage overlay method and SnCe6 was covalently conjugated to the bacteriophage 93 
using methods described previously.7  The concentration of SnCe6 bound to the 94 
phage was determined by spectral analysis against a calibration curve generated 95 
from known concentrations of SnCe6.  In different experiments, between 7.5 x 106 96 
and 4.7 x 107 cfu of bacteriophage were used in conjugation reactions and the 97 
amount of SnCe6 bound varied between 3.5 and 7 µg/mL. 98 
 99 
Lethal Photosensitisation Experiments 100 
Fifty microlitres of the Φ11-SnCe6 conjugate was added to 50 µL of bacterial 101 
suspension in a sterile 96-well plate.  The controls consisted of: SnCe6 alone (at the 102 
same concentration as the conjugate), Φ11 alone (at the same titre as the conjugate) 103 
and PBS control.  All of the mixtures were incubated in the dark, with stirring, for 30 104 
minutes prior to exposure to laser light.  The relevant samples were then sequentially 105 
exposed to laser light (632.8 nm) from a helium / neon (HeNe) gas laser with a 106 
measured power output of 29.2 mW (Spectra-Physics, Darmstadt-Kranichstein, 107 
Germany) for a period of 5 minutes; the mixtures were magnetically stirred 108 
throughout the course of an experiment.  Additional ‘dark controls’ were also 109 
conducted for these four variables without laser light.  The number of viable bacteria 110 
remaining in the samples was determined immediately following exposure to the 111 
laser light by serial dilution and enumeration of colony forming units on CBA.  Each 112 
experimental variable was repeated as a duplicate. 113 
 114 
The duplicate experiments with both strains of S. aureus were conducted a total of 115 
four times (n=8), whilst those for E. coli were repeated twice (n=4).  The null 116 
hypothesis was that there was no difference between the log10 counts of the number 117 
of colony forming units using various different experimental parameters, this was 118 
analysed by student’s t-test to yield p-values. 119 
 120 
121 
Results 122 
When compared to the control, which was not exposed to laser light nor to 123 
photosensitiser, the Φ11-SnCe6 conjugate in the presence of laser light yielded a 124 
2.31 log10 reduction (p=<0.05) in the number of viable bacteria recovered from the 125 
culture of S. aureus  8325-4 and a  2.63 log10 reduction (p=<0.05) for the culture of 126 
EMRSA16.  In the presence of laser light, the Φ11-SnCe6 conjugate did not result in 127 
significant killing of E. coli 10418.  None of the other combinations of controls (i.e. 128 
SnCe6 only, phage only and ‘dark controls’) produced significant bacterial kills 129 
(figure 1). 130 
 131 
Discussion 132 
We have previously shown that bacteriophage 75, a serotype F staphylococcal  133 
phage, could be used to target lethal photosensitisation to a range of S. aureus 134 
strains including strains it could not infect.  The capacity of bacteriophage 75 to 135 
target LP to a range of S. aureus strains was surprising since this phage has a 136 
restricted host range.  The question we asked in the current study was whether other 137 
staphylophage could target LP to a range of S. aureus strains, once conjugated to a 138 
photosensitiser, or if this was a specific trait of phage 75.  We did this by 139 
investigating the capacity of bacteriophage Φ11, a prototypic group B-transducing 140 
phage,9 to target lethal photosensitisation to S. aureus. 141 
 142 
When SnCe6 was conjugated to S. aureus bacteriophage Φ11, S. aureus strains 143 
8325-4 and EMRSA16 in the presence of laser light there was an increase in the 144 
killing of these bacteria by 2.39 log10 and 2.35 log10 respectively, when compared to 145 
the equivalent concentration of SnCe6 alone (i.e. free SnCe6 that was not 146 
conjugated to the bacteriophage).  Since it is known that staphylophage have the 147 
capacity to bind to all strains of S. aureus10 and bacteriophage Φ11 is not capable of 148 
infecting strain EMRSA16, the kill achieved by the Φ11-SnCe6 conjugate suggests 149 
that the photosensitiser-bacteriophage conjugate only needs to bind to the bacterial 150 
cell to induce killing in the presence of laser light.  The selectivity of the 151 
photosensitier-bacteriophage conjugate in targeting lethal photosensitisation to S. 152 
aureus was demonstrated by the inability to cause significant killing of E. coli in the 153 
presence of laser light. 154 
 155 
Our results demonstrate that it is possible to use different serotypes of 156 
staphylophage as vehicles to deliver photosensitiser payloads to the surface of S. 157 
aureus thus enabling selective lethal photosensitization of this bacterium in the 158 
presence of laser light.  Such designer composites would not only possess all of the 159 
advantages that photodynamic therapy has over conventional antibiotic therapy, as 160 
described in the introduction, but they would also ensure there was minimal collateral 161 
damage to the host and its indigenous microflora. 162 
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Figure Legend 172 
 173 
Figure 1.  The number of viable bacteria recovered following exposure of SnCe6-174 
bacteriophage 11 conjugate to laser light (leftmost columns) compared to controls.  175 
The designations L+ / L- and S+ / S- refer to the presence or absence of light and / 176 
or photosensitiser respectively. 177 
 178 
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